BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 2
• 3
• 4
• 5
• 6
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31

• Pharm Country

  Creative BioMart Launched Protein Phosphorylation Site Identification and Mapping Service

  Creative BioMart announced the release of Protein Phosphorylation Site Identification and Mapping Service to serve a broader range of scientists.

  October 25, 2017

   · 

  1 min read
• Drug Development

  Biogen Announces AFFINITY Phase II Trial Initiation for Opicinumab (Anti-LINGO-1) in Multiple Sclerosis

  The study was designed to evaluate opicinumab as an investigational add-on therapy in people with relapsing multiple sclerosis (MS).

  October 25, 2017

   · 

  6 min read
• Business

  Nine-Month Figures for 2017: Sartorius Continues to Grow Profitably in a Challenging Environment

  Sartorius, a leading international partner of the biopharmaceutical industry and research, recorded further growth in the first nine months of 2017 despite a partly challenging business environment.

  October 25, 2017

   · 

  9 min read
• Business

  GenSight Biologics Appoints Barrett Katz as Chief Medical Officer

  Dr. Katz replaces Mohamed Genead, M.D., who resigned from the position for personal reasons.

  October 25, 2017

   · 

  4 min read
• Business

  Medicrea Unveils New U.S. Business Development Model With Hiring of Joseph Walland As Executive Vice President of Sales and Richard Washburn as Executive Vice President UNiD™ ASI

  The Medicrea Group announced today that the Company has hired Joseph Walland as Executive Vice President of U.S. Sales, and Richard Washburn as Executive Vice President UNiD™ ASI, to support its new business development model in the United States, effective October 23, 2017.

  October 25, 2017

   · 

  3 min read
• Drug Development

  First Prospective Study of Robotic-Guided Spine Surgery Reveals Five-Fold Reduction in Surgical Complications With Mazor Core Technology

  At the North American Spine Society (NASS) Annual Meeting, a group including 10 investigators are presenting interim results from the first multi-center prospective study of robotic-guided spine surgery.

  October 25, 2017

   · 

  5 min read
• Business

  LabCorp Announces Record Third Quarter Results and Increases 2017 Guidance

  LabCorp today announced results for the third quarter ended September 30, 2017, and increased its 2017 guidance.

  October 25, 2017

   · 

  25 min read
• Pharm Country

  Newron Pharmaceuticals to Present at European Rett Syndrome Congress and Host Advisory Board Meeting

  Newron Pharmaceuticals S.p.A. today announced an oral presentation at the upcoming European Rett Syndrome Congress (“the congress”) in Berlin, Germany, November 2-4, 2017.

  October 25, 2017

   · 

  8 min read
• Genetown

  NantHealth’s Vitality Mobile App Now Available on Apple and Android Devices

  NantHealth today announced that its Vitality Mobile app is now available for download through the Apple and Google Play Stores.

  October 25, 2017

   · 

  5 min read
• Biotech Bay

  Veeva Announces Oncology Data Solution to Identify and Engage Scientific Leaders

  Veeva Systems today announced Veeva Oncology Link, an enterprise data solution to centralize insights and intelligence on scientific leaders in oncology.

  October 25, 2017

   · 

  4 min read